ISRGTICKER
Intuitive Surgical Inc.
Congress has disclosed 39 buys and 35 sells of ISRG (Intuitive Surgical Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
39
Buy
35
Sell
+4
Net
17
Active politicians
Round-trip watch Still on the books
Members who disclosed buying ISRG and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 | $452.66 | $432.01 | -4.6% | ↩ near entry |
| Jefferson Shreve | 2025-05-08 | $538.16 | $432.01 | -19.7% | underwater |
| Rohit Khanna | 2026-09-11 | $369.15 | $432.01 | +17.0% | in profit |
| Gilbert Cisneros | 2026-01-30 | $504.22 | $432.01 | -14.3% | underwater |
| Michael McCaul | 2026-08-07 | $378.81 | $432.01 | +14.0% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
50.64
▲ pricier than
Health (median 29.7)
how it's calculated
P/E = price ÷ earnings per share
$432.01 ÷ $8.53 = 50.64
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
9.37
▲ pricier than
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$432.01 ÷ $46.12 = 9.37
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
74 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-09-11 | 20 days | +8.7% | $1K–$15K | 54.6 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2026-08-10 | 22 days | -6.1% | $1K–$15K | 31.2 | ↗ filing |
| Michael McCaul | House | BUY OCR ◆ insider divergence | Spouse | 2026-08-07 | 29 days | -3.2% | $15K–$50K | 97.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2026-05-01 | 38 days | -8.6% | $1K–$15K | 9.6 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence | Self | 2026-03-27 | 116 days | -22.7% | $1K–$15K | 99.1 | ↗ eFD |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2026-01-30 | 12 days | -1.6% | $1K–$15K 0.1% of NW |
9.4 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-12-10 | 30 days | +5.5% | $1K–$15K 0.1% of NW |
13.8 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-11-18 | 24 days | -0.8% | $1K–$15K 0.1% of NW |
33.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2025-11-03 | 31 days | +4.5% | $1K–$15K | 14.4 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-09-03 | 34 days | -0.1% | $1K–$15K <0.1% of NW |
0.3 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-07-16 | 28 days | -5.9% | $1K–$15K 0.1% of NW |
65.1 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-07-10 | 34 days | -8.3% | $1K–$15K 0.1% of NW |
67.1 | ↗ filing |
| Lisa McClain | House | SELL ◆ insider convergence | Spouse · Charles Schwab Brokerage Account 924 | 2025-06-09 | 65 days | -8.3% | $1K–$15K 0.1% of NW |
84.7 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence | Self · CRT - Standard Unit Trust | 2025-05-08 | 7 days | +4.1% | $15K–$50K <0.1% of NW |
69.3 | ↗ filing |
| Bruce Westerman | House | SELL ◆ insider convergence | Self · Fisher IRA | 2025-04-21 | 7 days | +9.8% | $1K–$15K 0.7% of NW |
53.8 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-04-09 | 34 days | +7.8% | $1K–$15K <0.1% of NW |
13.3 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence | Joint · Merrill Lynch Long Term Growth | 2025-04-07 | 29 days | +14.4% | $1K–$15K <0.1% of NW |
82.3 | ↗ filing |
| Bruce Westerman | House | BUY ◆ insider divergence | Self · Fisher IRA | 2025-03-03 | 14 days | -13.8% | $1K–$15K 0.7% of NW |
65.4 | ↗ filing |
| Gilbert Cisneros | House | BUY ◆ insider divergence | Self · 150 Main Street Trust > Bank of America | 2025-01-30 | 7 days | +1.4% | $1K–$15K 0.1% of NW |
62.9 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-01-29 | 8 days | +2.8% | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-01-21 | 16 days | -2.6% | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-12-23 | 15 days | +0.9% | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Lisa McClain | House | BUY ◆ insider divergence | Spouse · Charles Schwab Brokerage Account 548 | 2024-12-11 | 243 days | -13.2% | $1K–$15K 0.1% of NW |
97.3 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-07-22 | 21 days | — | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Greg Landsman | House | SELL ◆ insider convergence | Joint · Rockefeller Capital Management (1) | 2024-07-17 | 22 days | — | $15K–$50K 2.3% of NW |
88.6 | ↗ filing |
| Greg Landsman | House | SELL ◆ insider convergence | Spouse · Sarah Landsman Traditional IRA | 2024-07-17 | 22 days | — | $1K–$15K 0.6% of NW |
64.6 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-06-25 | 13 days | — | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2024-06-07 | 25 days | — | $1K–$15K | 6.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-03-01 | 33 days | — | $1K–$15K | 8.6 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2024-01-29 | 9 days | — | $1K–$15K <0.1% of NW |
0.2 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-11-03 | 32 days | — | $1K–$15K | 10.6 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-10-27 | 11 days | — | $1K–$15K <0.1% of NW |
24.8 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
59.5 | ↗ filing |
| Greg Landsman | House | SELL ◆ insider convergence | Joint · Rockefeller Capital Management (1) | 2023-10-12 | 301 days | — | $1K–$15K 0.6% of NW |
93.1 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-09-01 | 34 days | — | $1K–$15K | 26.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-08-29 | 7 days | — | $1K–$15K | 31.8 | ↗ filing |
| Greg Landsman | House | SELL ◆ insider convergence | Joint · Rockefeller Capital Management (1) | 2023-08-02 | 372 days | — | $1K–$15K 0.6% of NW |
84.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-07-28 | 4 days | — | $1K–$15K | 52.4 | ↗ filing |
| William Keating | House | BUY ◆ insider divergence | Self · Bill's IRA | 2023-07-20 | 11 days | — | $1K–$15K 0.3% of NW |
86.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-07-07 | 25 days | — | $15K–$50K | 94.9 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-05-30 | 7 days | — | $1K–$15K <0.1% of NW |
2.6 | ↗ filing |
| Greg Landsman | House | BUY ◆ insider divergence | Joint · Rockefeller Capital Management (1) | 2023-05-30 | 436 days | — | $1K–$15K 0.6% of NW |
93.6 | ↗ filing |
| Greg Landsman | House | BUY ◆ insider divergence | Joint · Rockefeller Capital Management (1) | 2023-05-04 | 462 days | — | $1K–$15K 0.6% of NW |
96.2 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2023-05-01 | 36 days | — | $1K–$15K <0.1% of NW |
12.3 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $15K–$50K <0.1% of NW |
56.6 | ↗ filing |
| Greg Landsman | House | BUY ◆ insider divergence | Spouse · Sarah Landsman Traditional IRA | 2023-02-01 | 554 days | — | $1K–$15K 0.6% of NW |
99.3 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-01-31 | 9 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Kathy Manning | House | SELL | Spouse · The 2011 Randall R. Kaplan Living Trust > MV Capital - Brokerage #3 | 2022-10-12 | 23 days | — | $1K–$15K 0.1% of NW |
10.6 | ↗ filing |
| John Curtis | House | SELL | Joint · Northwestern Mutual - Joint | 2022-06-28 | 3 days | — | $1K–$15K | 31.8 | ↗ filing |
| Kathy Manning | House | SELL | Joint · Charles Schwab - Edgewood Management LLC C: Remaining shares transferred to a Donor Advised Fund | 2022-06-10 | 25 days | — | $1K–$15K 0.1% of NW |
26.5 | ↗ filing |
| Kathy Manning | House | BUY | Joint | 2022-02-23 | 8 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2022-01-26 | 12 days | — | $1K–$15K <0.1% of NW |
2.6 | ↗ filing |
| Kathy Manning | House | SELL | Joint | 2021-12-01 | 70 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| John Curtis | House | BUY | Self | 2021-06-22 | 9 days | — | $1K–$15K | 40.4 | ↗ filing |
| Kathy Manning | House | SELL | Joint | 2021-05-04 | 281 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2021-02-23 | 10 days | — | $1K–$15K <0.1% of NW |
13.4 | ↗ filing |
| Peter Meijer | House | SELL | Self | 2021-02-16 | 3 days | — | $1K–$15K | 86.8 | ↗ filing |
| Donald Sternoff Beyer | House | SELL | Joint | 2020-05-01 | 30 days | — | $1K–$15K <0.1% of NW |
17.4 | ↗ filing |
| Donald Sternoff Beyer | House | SELL | Joint | 2020-04-27 | 9 days | — | $1K–$15K <0.1% of NW |
18.1 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2020-04-17 | 19 days | — | $1K–$15K <0.1% of NW |
14.1 | ↗ filing |
| John Curtis | House | BUY | Self | 2020-03-27 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2020-01-28 | 5 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-12-23 | 10 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-12-09 | 5 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-11-22 | 14 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Donald Sternoff Beyer | House | BUY | Joint | 2019-11-19 | 17 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2019-09-20 | 17 days | — | $1K–$15K <0.1% of NW |
6.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2019-07-16 | 29 days | — | $1K–$15K <0.1% of NW |
8.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2019-04-15 | 24 days | — | $1K–$15K <0.1% of NW |
10.6 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2018-10-01 | 35 days | — | $1K–$15K <0.1% of NW |
15.7 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2018-08-10 | 46 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2018-08-07 | 49 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Josh Gottheimer | House | BUY | Joint | 2017-11-07 | 274 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in ISRG — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
18
Congress trades with insider convergence
30
…with insider divergence
373
Insider open-market trades
Of the congressional trades in ISRG, 18 coincided with corporate insiders moving the same way within 60 days, and 30 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-30 | Widman Fredrik | Other | SELL 10b5-1 | $2.4M | ↗ EDGAR |
| 2026-10-30 | Brosius Mark | C-suite | SELL 10b5-1 | $29K | ↗ EDGAR |
| 2026-10-29 | Brosius Mark | C-suite | SELL 10b5-1 | $27K | ↗ EDGAR |
| 2026-10-28 | Brosius Mark | C-suite | SELL 10b5-1 | $27K | ↗ EDGAR |
| 2026-10-27 | Brosius Mark | C-suite | SELL 10b5-1 | $28K | ↗ EDGAR |
| 2026-10-26 | Brosius Mark | C-suite | SELL 10b5-1 | $28K | ↗ EDGAR |
| 2026-10-23 | WADORS PATRICIA L | C-suite | SELL 10b5-1 | $478K | ↗ EDGAR |
| 2026-10-23 | BARRATT CRAIG H | Director | SELL 10b5-1 | $510K | ↗ EDGAR |
| 2026-10-23 | GUTHART GARY S | Director | SELL 10b5-1 | $9.1M | ↗ EDGAR |
| 2026-10-23 | Widman Fredrik | Other | SELL 10b5-1 | $1.8M | ↗ EDGAR |
| 2026-09-15 | Widman Fredrik | Other | SELL 10b5-1 | $204K | ↗ EDGAR |
| 2026-09-15 | Widman Fredrik | Other | SELL 10b5-1 | $203K | ↗ EDGAR |
| 2026-09-11 | Brosius Mark | C-suite | SELL 10b5-1 | $9K | ↗ EDGAR |
| 2026-09-10 | Brosius Mark | C-suite | SELL 10b5-1 | $8K | ↗ EDGAR |
| 2026-09-09 | Brosius Mark | C-suite | SELL 10b5-1 | $8K | ↗ EDGAR |
| 2026-09-08 | Brosius Mark | C-suite | SELL 10b5-1 | $17K | ↗ EDGAR |
| 2026-08-21 | Brosius Mark | C-suite | SELL 10b5-1 | $29K | ↗ EDGAR |
| 2026-08-20 | Brosius Mark | C-suite | SELL 10b5-1 | $31K | ↗ EDGAR |
| 2026-08-19 | Brosius Mark | C-suite | SELL 10b5-1 | $30K | ↗ EDGAR |
| 2026-08-18 | Brosius Mark | C-suite | SELL 10b5-1 | $30K | ↗ EDGAR |
| 2026-08-17 | Brosius Mark | C-suite | SELL 10b5-1 | $30K | ↗ EDGAR |
| 2026-08-11 | Ladd Amy L | Director | SELL 10b5-1 | $28K | ↗ EDGAR |
| 2026-08-11 | GUTHART GARY S | Director | SELL 10b5-1 | $4.0M | ↗ EDGAR |
| 2026-08-10 | LOEB GARY | C-suite | SELL 10b5-1 | $152K | ↗ EDGAR |
| 2026-08-10 | Ladd Amy L | Director | SELL 10b5-1 | $152K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-30 | Widman Fredrik Other 10b5-1 | SELL | $2.4M |
| ◆ insider | 2026-10-30 | Brosius Mark C-suite 10b5-1 | SELL | $29K |
| ◆ insider | 2026-10-29 | Brosius Mark C-suite 10b5-1 | SELL | $27K |
| ◆ insider | 2026-10-28 | Brosius Mark C-suite 10b5-1 | SELL | $27K |
| ◆ insider | 2026-10-27 | Brosius Mark C-suite 10b5-1 | SELL | $28K |
| ◆ insider | 2026-10-26 | Brosius Mark C-suite 10b5-1 | SELL | $28K |
| ◆ insider | 2026-10-23 | WADORS PATRICIA L C-suite 10b5-1 | SELL | $478K |
| ◆ insider | 2026-10-23 | BARRATT CRAIG H Director 10b5-1 | SELL | $510K |
| ◆ insider | 2026-10-23 | GUTHART GARY S Director 10b5-1 | SELL | $9.1M |
| ◆ insider | 2026-10-23 | Widman Fredrik Other 10b5-1 | SELL | $1.8M |
| ◆ insider | 2026-09-15 | Widman Fredrik Other 10b5-1 | SELL | $204K |
| ◆ insider | 2026-09-15 | Widman Fredrik Other 10b5-1 | SELL | $203K |
| Congress | 2026-09-11 | Rohit Khanna | BUY | $1K–$15K |
| ◆ insider | 2026-09-11 | Brosius Mark C-suite 10b5-1 | SELL | $9K |
| ◆ insider | 2026-09-10 | Brosius Mark C-suite 10b5-1 | SELL | $8K |
| ◆ insider | 2026-09-09 | Brosius Mark C-suite 10b5-1 | SELL | $8K |
| ◆ insider | 2026-09-08 | Brosius Mark C-suite 10b5-1 | SELL | $17K |
| ◆ insider | 2026-08-21 | Brosius Mark C-suite 10b5-1 | SELL | $29K |
| ◆ insider | 2026-08-20 | Brosius Mark C-suite 10b5-1 | SELL | $31K |
| ◆ insider | 2026-08-19 | Brosius Mark C-suite 10b5-1 | SELL | $30K |
| ◆ insider | 2026-08-18 | Brosius Mark C-suite 10b5-1 | SELL | $30K |
| ◆ insider | 2026-08-17 | Brosius Mark C-suite 10b5-1 | SELL | $30K |
| ◆ insider | 2026-08-11 | Ladd Amy L Director 10b5-1 | SELL | $28K |
| ◆ insider | 2026-08-11 | GUTHART GARY S Director 10b5-1 | SELL | $4.0M |
FAQ Common questions
How much has Congress traded ISRG?
39 disclosed buys and 35 sells of ISRG (Intuitive Surgical Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade ISRG?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.